• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacological treatment of COPD: the devil is always in the detail.

作者信息

Singh Dave, Barnes Peter J, Stockley Robert, Lopez Valera Maria Victorina, Vogelmeier Claus, Agusti Alvar

机构信息

University of Manchester, Medicines Evaluation Unit, Manchester University NHS Foundation Hospital Trust, Manchester, UK.

National Heart and Lung Institute, University of London Imperial College, London, UK.

出版信息

Eur Respir J. 2018 Apr 19;51(4). doi: 10.1183/13993003.00263-2018. Print 2018 Apr.

DOI:10.1183/13993003.00263-2018
PMID:29674480
Abstract
摘要

相似文献

1
Pharmacological treatment of COPD: the devil is always in the detail.慢性阻塞性肺疾病的药物治疗：细节决定成败。
Eur Respir J. 2018 Apr 19;51(4). doi: 10.1183/13993003.00263-2018. Print 2018 Apr.
2
Chronic Obstructive Pulmonary Disease Endotypes in Low- and Middle-Income Country Settings: Precision Medicine for All.低收入和中等收入国家背景下的慢性阻塞性肺疾病内型：全民精准医疗
Am J Respir Crit Care Med. 2020 Jul 15;202(2):171-172. doi: 10.1164/rccm.202001-0165ED.
3
"Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.".“慢性阻塞性肺疾病和表型：最新进展。”
Pulmonology. 2020 Mar-Apr;26(2):95-100. doi: 10.1016/j.pulmoe.2019.10.006. Epub 2019 Nov 15.
4
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病药理学治疗的当前争议。
Am J Respir Crit Care Med. 2016 Sep 1;194(5):541-9. doi: 10.1164/rccm.201606-1179PP.
5
[Waste of resources counteracts individualized COPD treatment].资源浪费阻碍慢性阻塞性肺疾病个体化治疗
Lakartidningen. 2017 Apr 20;114:ELXS.
6
Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap.哮喘-慢性阻塞性肺疾病重叠综合征的治疗方法
Expert Rev Clin Immunol. 2017 May;13(5):449-455. doi: 10.1080/1744666X.2017.1273109. Epub 2016 Dec 26.
7
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?慢性阻塞性肺疾病当前管理概述：我们能否超越 GOLD 建议？
Expert Rev Respir Med. 2018 Jan;12(1):43-54. doi: 10.1080/17476348.2018.1398086. Epub 2017 Nov 3.
8
[New GOLD guidelines for the therapy of COPD].[慢性阻塞性肺疾病治疗的新全球倡议（GOLD）指南]
Pneumologie. 2012 Dec;66(12):768. doi: 10.1055/s-0032-1326007. Epub 2012 Dec 6.
9
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.吸入性糖皮质激素在慢性阻塞性肺疾病中的应用：从畅销药物到精准医学
COPD. 2017 Dec;14(6):641-647. doi: 10.1080/15412555.2017.1385056. Epub 2017 Nov 8.
10
[The cutting-edge of medicine; cutting edge of COPD therapy].[医学前沿；慢性阻塞性肺疾病治疗前沿]
Nihon Naika Gakkai Zasshi. 2013 Jul 10;102(7):1822-8. doi: 10.2169/naika.102.1822.

引用本文的文献

1
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis.布地奈德/福莫特罗/格隆溴铵三联超细微固定剂量组合对慢性阻塞性肺疾病症状和肺功能的真实世界有效性：一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 May 27;20:1723-1736. doi: 10.2147/COPD.S511334. eCollection 2025.
2
Prognostic risk profiling in COPD using Global Initiative for Chronic Obstructive Lung Disease 2023 ABE and comorbidity assessment: evidence from a register-based COPD cohort.使用慢性阻塞性肺疾病全球倡议组织2023年ABE和合并症评估对慢性阻塞性肺疾病进行预后风险评估：来自基于登记的慢性阻塞性肺疾病队列的证据
J Glob Health. 2025 May 23;15:04152. doi: 10.7189/jogh.15.04152.
3
Experimental Mouse Models and Human Lung Organoid Models for Studying Chronic Obstructive Pulmonary Disease.用于研究慢性阻塞性肺疾病的实验小鼠模型和人肺类器官模型
Biomol Ther (Seoul). 2024 Nov 1;32(6):685-696. doi: 10.4062/biomolther.2024.148. Epub 2024 Oct 16.
4
New Perspectives on Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的新视角。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 6;17:2127-2136. doi: 10.2147/COPD.S365771. eCollection 2022.
5
The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.TRIFLOW 研究：一项随机、交叉研究，评估了超细布地奈德/福莫特罗/格隆溴铵对 COPD 患者气体陷闭的影响。
Respir Res. 2020 Dec 9;21(1):323. doi: 10.1186/s12931-020-01589-5.
6
Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.反映慢性阻塞性肺疾病及相关呼吸系统疾病的动物模型：将临床前数据转化为临床相关性。
J Innate Immun. 2020;12(3):203-225. doi: 10.1159/000502489. Epub 2019 Sep 17.
7
When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.慢性阻塞性肺疾病（COPD）何时使用单吸入器三联疗法：基层医疗保健专业人员的实用方法
Int J Chron Obstruct Pulmon Dis. 2019 Feb 13;14:391-401. doi: 10.2147/COPD.S173901. eCollection 2019.